These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23181175)
1. High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI - The Tamip Study. Balghith MA Heart Views; 2012 Jul; 13(3):85-90. PubMed ID: 23181175 [TBL] [Abstract][Full Text] [Related]
2. Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban. van 't Hof AW; Valgimigli M Drugs; 2009; 69(1):85-100. PubMed ID: 19192938 [TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study. Kochman W; Dobrzycki S; Nowak KS; Chlopicki S; Kralisz P; Prokopczuk P; Bachorzewska-Gajewska H; Gugala K; Niewada M; Mezynski G; Poniatowski B; Korecki J; Musial WJ J Thromb Thrombolysis; 2004 Apr; 17(2):127-31. PubMed ID: 15306748 [TBL] [Abstract][Full Text] [Related]
4. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Hermanides RS; van Werkum JW; Ottervanger JP; Breet NJ; Gosselink AT; van Houwelingen KG; Dambrink JH; Hamm C; ten Berg JM; van 't Hof AW; Catheter Cardiovasc Interv; 2012 May; 79(6):956-64. PubMed ID: 22162050 [TBL] [Abstract][Full Text] [Related]
5. The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI. Kaymaz C; Keleş N; Özdemir N; Tanboğa İH; Demircan HC; Can MM; Koca F; İzgi İA; Özkan A; Türkmen M; Kırma C; Esen AM Anatol J Cardiol; 2015 Nov; 15(11):899-906. PubMed ID: 25868037 [TBL] [Abstract][Full Text] [Related]
6. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629 [TBL] [Abstract][Full Text] [Related]
7. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. Montalescot G; Borentain M; Payot L; Collet JP; Thomas D JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852 [TBL] [Abstract][Full Text] [Related]
8. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update. Cohen M Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045 [TBL] [Abstract][Full Text] [Related]
9. [Effect of pre-angiography use of tirofiban in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention]. Xu L; Yang XC; Wang LF; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Cui L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):983-6. PubMed ID: 17288757 [TBL] [Abstract][Full Text] [Related]
10. Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty. Bilsel T; Akbulut T; Yesilcimen K; Terzi S; Sayar N; Dayi SU; Akgoz H; Ergelen M; Ciloglu F Heart Vessels; 2006 Mar; 21(2):102-7. PubMed ID: 16550311 [TBL] [Abstract][Full Text] [Related]
11. Intracoronary Reopro during Percutaneous Coronary Intervention in Acute and Stable Patient can Influence Stent Thrombosis Formation (IRPASST) Study. Balghith M; Al-Ghamdi A; Zain el H; Al-Saileek A Heart Views; 2013 Apr; 14(2):62-7. PubMed ID: 23983910 [TBL] [Abstract][Full Text] [Related]
13. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of early versus late glycoprotein IIb/IIIa inhibitors for PCI. Xu Q; Yin J; Si LY Int J Cardiol; 2013 Jan; 162(3):210-9. PubMed ID: 22769575 [TBL] [Abstract][Full Text] [Related]
15. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. Valgimigli M; Tebaldi M; Campo G; Gambetti S; Bristot L; Monti M; Parrinello G; Ferrari R; JACC Cardiovasc Interv; 2012 Mar; 5(3):268-77. PubMed ID: 22440491 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial. Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755 [TBL] [Abstract][Full Text] [Related]
17. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective. Dyke CM Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236 [TBL] [Abstract][Full Text] [Related]
18. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892 [TBL] [Abstract][Full Text] [Related]
19. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806 [TBL] [Abstract][Full Text] [Related]
20. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]